Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 91. Capino A C, Miller J L, Johnson P N. Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children. Pharmacotherapy. 2016; 36 : 1290-1299
92. Ibach B W, Johnson P N, Ernst K D, Harrison D, Miller J L. Initial dosing and taper complexity of methadone and morphine for treatment of neonatal abstinence syndrome. Journal of Pharmacy Technology. 2016; 32 : 216-22
93. Johnson P N, Miller J L, Hagemann T M, Moffett B S. Assessment of inpatient admissions and top 25 medications for obese pediatric patients at two academic hospitals. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2016; 73 : 1243-9
94. Van Tuyl J S, Jones A N, Johnson P N. Meropenem-Induced Neutropenia in a Neonate. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2016; 21 : 353-357
95. Ibach B W, Miller J L, Woo S, Harrison D, Standifer K, Hagemann T M, Johnson P N. Characterization of tolerance in children receiving fentanyl continuous infusions. Journal of Pediatric Intensive Care. 2016
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 11. American Association for Colleges of Pharmacy. Walmart Scholar Mentor (for Katy Stephens). Date: 2018.
12. Oklahoma Society of Health-System Pharmacists Pharmacist of the Year. Date: 2018.
13. Oklahoma University Health Sciences Center. Provost's Teaching Award--Seasoned Faculty. Date: 2018.
14. American College of Critical Care Medicine. Fellow (FCCM). Date: 2018.
15. OU Health Sciences Center Student Government Association. Robert Magarian Faculty Award. Date: 2017.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results